| Leila Stephane Joseph, DO | |
|
100 Lincoln Hwy, Fairless Hills, PA 19030-1008 | |
| (267) 587-0775 | |
| Not Available |
| Full Name | Leila Stephane Joseph |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 100 Lincoln Hwy, Fairless Hills, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124694807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OT020857 (Pennsylvania) | Secondary |
| 207Q00000X | Family Medicine | OS023150 (Pennsylvania) | Primary |
| Entity Name | Patient First Pennsylvania Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194039560 PECOS PAC ID: 5193900280 Enrollment ID: O20110505000465 |
News Archive
Scientists involved in the EU-funded project ChildInnovac are about to publish in the online journal Plos One the results of their first clinical trial of a new nasal vaccine.
Researchers at Brigham and Women's Hospital have engineered cancer cells that track and kill cancer cells. The modified cancer cells have demonstrated anti-cancer efficacy in preclinical studies, destroying both primary and metastatic tumours.
A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.
Johns Hopkins researchers have identified the proteins that allow specific brain cells to "change channels," a rare ability that tweaks what can come into the cell. The findings, described in the March 24 issue of Neuron, might let researchers harness the process, perhaps one day using it to protect cells that die in Lou Gehrig's disease.
› Verified 4 days ago
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191216001523 |
News Archive
Scientists involved in the EU-funded project ChildInnovac are about to publish in the online journal Plos One the results of their first clinical trial of a new nasal vaccine.
Researchers at Brigham and Women's Hospital have engineered cancer cells that track and kill cancer cells. The modified cancer cells have demonstrated anti-cancer efficacy in preclinical studies, destroying both primary and metastatic tumours.
A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.
Johns Hopkins researchers have identified the proteins that allow specific brain cells to "change channels," a rare ability that tweaks what can come into the cell. The findings, described in the March 24 issue of Neuron, might let researchers harness the process, perhaps one day using it to protect cells that die in Lou Gehrig's disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leila Stephane Joseph, DO 2517 Dunksferry Rd Apt K108, Bensalem, PA 19020-2742 Ph: () - | Leila Stephane Joseph, DO 100 Lincoln Hwy, Fairless Hills, PA 19030-1008 Ph: (267) 587-0775 |
News Archive
Scientists involved in the EU-funded project ChildInnovac are about to publish in the online journal Plos One the results of their first clinical trial of a new nasal vaccine.
Researchers at Brigham and Women's Hospital have engineered cancer cells that track and kill cancer cells. The modified cancer cells have demonstrated anti-cancer efficacy in preclinical studies, destroying both primary and metastatic tumours.
A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.
Johns Hopkins researchers have identified the proteins that allow specific brain cells to "change channels," a rare ability that tweaks what can come into the cell. The findings, described in the March 24 issue of Neuron, might let researchers harness the process, perhaps one day using it to protect cells that die in Lou Gehrig's disease.
› Verified 4 days ago
Dr. Eric M Kephart, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Lincoln Hwy, Fairless Hills, PA 19030 Phone: 267-587-0775 | |
Richard Bruce Taddonio, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 N Oxford Valley Rd, Ste 201, Fairless Hills, PA 19030 Phone: 215-946-1500 Fax: 215-946-3417 | |
Gregory R Gordon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 N Oxford Valley Rd, Ste 201, Fairless Hills, PA 19030 Phone: 215-946-1500 Fax: 215-946-3417 | |
Shanae Nguyen, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Lincoln Hwy, Fairless Hills, PA 19030 Phone: 267-587-0775 | |
Chaitali J. Patel, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Lincoln Hwy, Fairless Hills, PA 19030 Phone: 267-587-0775 | |
Dr. Mark Liebreich, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 N Oxford Valley Rd, Suite 201, Fairless Hills, PA 19030 Phone: 215-946-1500 Fax: 215-946-3417 |